Medicare – Page 10

Drugmakers Throw ‘Kitchen Sink’ to Halt Medicare Price Negotiations

The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.

By Sheryl Gay Stolberg and Rebecca Robbins

Blue Cross and Blue Shield of Michigan Boston Scientific Corporation Brookshire, Dr. Ralph Doctors Finances Grand Rapids (Mich) Justice Department Koninklijke Philips Electronics NV McGuckin, Dr. James Medical Devices Medicare Mustapha, Dr. Jihad Peripheral Vascular Disease Saab, Dr. Fadi Surgery and Surgeons

Profiting From Risky Atherectomies That Can Lead to Amputations

Medical device makers have bankrolled a cottage industry of doctors and clinics that perform artery-clearing procedures that can lead to amputations.

By Katie Thomas Jessica Silver-Greenberg and Robert Gebeloff

Brain Content Type: Service Drugs (Pharmaceuticals) Food and Drug Administration Health Insurance and Managed Care Medicare

What to Know About Leqembi, the Alzheimer’s Drug Approved by the FDA

Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.

By Pam Belluck

Biogen Inc Centers for Medicare and Medicaid Services Decisions and Verdicts Drugs (Pharmaceuticals) Eisai Co Ltd Food and Drug Administration Medicare Memory United States

FDA Makes Alzheimer’s Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.

By Pam Belluck

mosaec